Declining interest rates and increased antitrust scrutiny against private equity in healthcare could further impact activity in 2024.
Private equity transactions declined in almost every health specialty in 2023, with cardiology, medspas and clinical trial sites among the few seeing growth.
Healthcare’s private equity deal count from 2017 to 2023:
2017: 445
2018: 595
2019: 649
2020: 772
2021: 1,114
2022: 940
2023: 788
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.